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Abstract: Brain injury is a significant source of morbidity and mortality for pediatric patients treated
with Extracorporeal Membrane Oxygenation (ECMO). Our objective was to utilize neural networks
to predict radiographic evidence of brain injury in pediatric ECMO-supported patients and identify
specific variables that can be explored for future research. Data from 174 ECMO-supported patients
were collected up to 24 h prior to, and for the duration of, the ECMO course. Thirty-five variables
were collected, including physiological data, markers of end-organ perfusion, acid-base homeostasis,
vasoactive infusions, markers of coagulation, and ECMO-machine factors. The primary outcome
was the presence of radiologic evidence of moderate to severe brain injury as established by brain
CT or MRI. This information was analyzed by a neural network, and results were compared to a
logistic regression model as well as clinician judgement. The neural network model was able to
predict brain injury with an Area Under the Curve (AUC) of 0.76, 73% sensitivity, and 80% specificity.
Logistic regression had 62% sensitivity and 61% specificity. Clinician judgment had 39% sensitivity
and 69% specificity. Sequential feature group masking demonstrated a relatively greater contribution
of physiological data and minor contribution of coagulation factors to the model's performance.
These findings lay the foundation for further areas of research directions.
Keywords: ECMO; neurologic injury; brain injury; machine learning; neural networks; pediatrics
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1. Introduction
The use of Extracorporeal Membrane Oxygen (ECMO) in children has increased significantly
over the last two decades [1,2]. Despite advances in ECMO science, the incidence of ECMO-related
brain injuries remains high [3]. For children supported with ECMO who develop brain injury,
survival is greatly reduced. Survivors with brain injury also have poor developmental and functional
outcomes [4–8].
The etiology of brain injury is likely multifactorial. The severity of pre-ECMO illness and
underlying comorbidities can predispose certain patients to develop an injury. Thromboembolic
and hemorrhagic complications associated with extracorporeal support also contribute to injury risk.
The extraordinary scope of data associated with an ECMO run has presented a challenge in elucidating
the factors that most significantly contribute to brain injury risk and have limited development of
a predictive model. This is partly due to the complex interactions between clinical and mechanical
variables that limit the ability of traditional statistical methods to decipher causative factors or to generate
an accurate prediction model. Existing research focuses on evaluating singular distinct elements,
such as underlying illness, coagulation abnormalities, anticoagulation management, or markers of
end-organ perfusion as factors associated with brain injury [9–12]. Many published models are limited
to either pediatric or neonatal patients and have a narrow set of ECMO indications [13,14]. Prior studies
do not take into consideration the temporal and dynamic element of clinical events that may play a
large role in the genesis of brain injury, and few explore which variables may be predictive of injury
without the bias of pre-selecting variables of interest.
Machine learning is a form of artificial intelligence that employs algorithms to elucidate patterns
in an iterative manner, optimizing tasks such as prediction. The strength of neural networks lies in the
ability to combine multiple factors, analyze their influence on each other, and incorporate temporal
relationships in a model [15]. We hypothesized that neural network models utilizing temporal clinical
data from prior and during the ECMO run in a large pediatric and neonatal ECMO population would
predict radiographic brain injury. We further hypothesized that iterative feature masking would help to
discriminate factors associated with the predictive ability of the model, and may guide future research
avenues to mitigate neurological injuries. The overall purpose of the study is to gain some mechanistic
insight that allows hypothesis generation for future studies into ECMO-related neurological injuries.
2. Materials and Methods
2.1. Study Oversight
This single-center observational cohort study was conducted in accordance with the ethical
standards of the Committee for the Protection of Human Subjects at both University of Texas
Southwestern Medical Center and Children’s Health. The institutional review board (IRB) at the
University of Texas Southwestern Medical Center approved the parent study in 2015, and modification
to include data for our study was approved in March of 2018. The need for consent was waived due to
the retrospective nature of the study and deidentification of data.
2.2. Patients
We queried our institutional ECMO database to identify children supported on ECMO in our
tertiary pediatric and cardiac intensive care units between 1 January 2010 and 31 June 2019. As in
Figure 1, a total of 422 ECMO runs occurred in that time period. All patients who received ECMO during
this time for any indication were eligible. This included patients who were cannulated in the setting
of extracorporeal cardiopulmonary resuscitation (ECPR). We excluded patients missing advanced
neuroimaging in the form of either intra ECMO or CT or post-ECMO brain MRI/CT, as diagnosis of
neurological injury was made by advanced neuroimaging. A small subset of patients died before
imaging was performed; however, if they had head CTs prior to their death they were included in
the analysis.
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We also excluded cardiac bypass recipients since variable data from the operating room was not
available. Due to imaging occurring post-ECMO, thus any clinical change that increased injury risk or
injury itself that occurred during bypass would falsely be attributed to the ECMO run. No patients
were lost to follow-up; all data were obtained within the hospitalization. After selection, 174 patients
remained, with more than 35,000 ECMO hours and 1.4 million data points across 35 variables.J. Clin. Med. 2020, 9, x FOR PEER REVI W 3 of 14 
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outcomes to allow the inclusion of patients who expired on ECMO or died prior to hospital discharge. 
In this population, neuroimaging has been correlated with neurodevelopmental outcomes[19–21]. 
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All information was extracted from the Epic™ electronic health records system. Any aberrant or 
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2.3. Brain Injury and Neuroimaging
The primary outcome was radiographic evidence of moderate to severe ischemic or hemorrhagic
brain injury as categorized on computerized tomography (CT) or magnetic resonance imaging (MRI).
Radiologic studies were either performed during ECMO or post-decannulation. MRIs were typically
performed within a week of decannulation for patients supported with ECMO for non-cardiac
indications. Head CT scans during ECMO were performed for acute clinical concern at the discretion
of the primary ECMO physician. For patients who had a CT during ECMO as well as additional
imaging (CT or MRI) post ECMO decannulation, brain imaging performed following ECMO was used
for identifyin brain injury. All head imaging was reviewed by a pediatric neuroradiologist b inded to
clinical infor ation. A random sample of ten images was reviewed by an independent neuroradiologist,
who was blinded to imaging scores determined by the initial review. Scores assigned by both radiologists
were reviewed for concordance. Cohen’s Kappa statistic was 0.82, indicating near-perfect agreement
between the reviewers.
The diagnostic accuracy of these modalities in hemorrhagic brain injury [16] and ischemic brain
injury has been reported previously [16–18]. Imaging was us ins ead of neurodevelopmental
outcome to allow the inclusion of patients ho expired on ECMO or died rior to hospital discharge.
In this population, neuroimaging has been correlated with neurodevelopmental outcomes [19–21].
2.4. Data Collection and Sources
Data were collected startin at 24 h prior to ECMO and for the entire duration of ECMO support.
All information was extracted from the Epic™ electronic health records system. Any aberrant or
missing data points prompted a manual review of the patient’s chart for reconciliation. No patients
had missing d ta points in the final dataset. Physiologic and medication infusi n data were imported
hourly into the EHR automatically from physiologic monitors and manually verified y nursing staff.
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Laboratory values were inputted into the system automatically or by laboratory personnel; these were
available at varying intervals based on ordered frequency. ECMO pump factors were available on an
hourly basis for the duration of the run, as recorded by the ECMO specialist.
2.5. Data Organization
We extracted 35 variables and organized them into six distinct clinical groups as seen in Table A1.
Physiologic data included systolic blood pressure, diastolic blood pressure, mean arterial blood pressure,
heart rate, oxygen saturation (SpO2), and temperature (Celsius). Blood pressure measurements were
based off of invasive arterial blood pressure catheters. Acid/Base homoeostasis factors collected were
arterial pH, arterial partial pressure of carbon dioxide (PCO2), arterial partial pressure of oxygen (PaO2)
and base excess. Surrogates of end-organ perfusion were collected including alanine aminotransferase
(ALT), aspartate aminotransferase (AST), creatinine, lactate, and bilirubin. Serum glucose data were also
collected. Markers of coagulation and hemolysis were collected and included International Normalized
Ratio (INR), prothrombin time (PTT), platelet count, fibrinogen, hemoglobin, free hemoglobin,
and heparin drip infusion rates (units/kg/h). Vasoactive data included: epinephrine, dopamine,
norepinephrine, and milrinone infusion rates all as micrograms/kg/min; vasopressin infusion rate
in units/kg/h; these values were also used to calculate a vasoactive infusion score (VIS) [22]. Lastly,
we collected ECMO mechanical data including pressures pre-oxygenator, post-oxygenator, pressure
at the volume sensor, measured flow (mL/kg/h), oxygenator FiO2, and sweep (L/min). All available
variables were inputted with no prior preselection to minimize underlying bias factoring into the
model, with the exception of age and diagnosis—these were excluded to limit leakage to the model.
2.6. Machine Learning Methods
Figure 2 shows the architecture of the machine learning algorithm. The network input is the
raw multi-dimensional clinical data and the output is the predicted label of injury. The resulting
neural network was composed of two main components in parallel, a convolutional network and a
recurrent network.
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and global pooling layers). Inputs were variables listed, with outputs being neurological injury 
classification. 
Figure 2. Machine learning architecture of the model used in the study. Hybrid neural network
constructed of a recurrent neural network (Long Short-term Memory followed by dropout layer)
and convolutional neural network (convolutional, Rectified linear unit (ReLU) activation unit and
dropout and global pooling layers). Inputs were variables listed, with outputs being neurological
injury classification.
The Convolutional Neural Network (CNN) consisted of a 1-dimensional convolutional layer
with 16 filters and a kernel size of 5. It utilized rectified linear (ReLU) activation factors as well as a
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batch normalization layer. A global average pooling layer was then applied to generate the spatial
information in each dimension. The Recurrent Neural Network (RNN) consisted of a Gated Recurrent
Unit (GRU) with 16 hidden units. Two sets of abstract features extracted from both the CNN and RNN
were concatenated into a new fully connected layer. Finally, the hybrid neural network and new linked
layer generated an output for estimating radiographic brain injury probability through a softmax layer
for classifications. The hybrid model was compared to individual RNN, CNN and a simple LTSM and
demonstrated improved accuracy and F1 score.
We implemented our approach using Keras with Tensorflow 1.9 software (Mountain View, CA,
USA) as our back-end platform [23]. Temporal samples were extracted at regular intervals. The deep
learning model was trained by minimizing the cross-entropy loss using the Adam optimizer [24].
Hyper-parameter settings were 300 learning epochs and a stochastic gradient descent with initial
learning rate of 0.0001. To obtain a robust process of modeling, all training samples were randomly
shuffled in each epoch before feeding into the model. We performed all experiments on a remote
server (UTSouthwestern BioHPC–Dallas, TX, USA) and utilized a computing cluster equipped with a
NVIDIA Tesla P100 GPU and 72 CPUs with 256 GB memory(Santa Clara, CA, USA).
To evaluate the model performance and capability for generalizing new samples, we used 5-fold
cross-validation settings that consist of multiple rounds. For the i-th round (i = 1, . . . , 5), the data were
randomly split into a subset (80%) for training the model and the other subset (20%) was hold out for
testing. In order to reduce any evaluation bias, the results in the testing sets over five rounds were
averaged to give an estimate of model performance. We further limited the model to the first 48 and
120 h (including the 24 h prior to ECMO cannulation) to evaluate how the duration of recording would
affect the ability to predict radiographic brain injury.
To improve post-hoc interpretability of our model, we removed groups of variables (specified in
methods) and observed the overall effect on model accuracy. This was done by a machine learning
technique known as feature masking, with the goal to elucidate the importance of variable groups to
the models accuracy [25]. Following removal of each group, the model was once again validated with
k-fold cross validation with the same 5-fold model evaluation setting, and the overall average accuracy
and resulting confusion matrices were reported.
2.7. Clinician Suspicion for Injury
We reviewed all patients’ medical records to ascertain if brain injury was suspected during
the ECMO run based on clinical assessment, prior to obtaining any imaging. This review included
physician and advanced practice provider notes, subspecialty consults, and all requested imaging
studies. We compared these findings with the results of imaging obtained following ECMO.
2.8. Logistic Regression
For each variable, four features were extracted over the initial 48 h: minimum, maximum,
median value and slope. Data were limited to 48 h, as it was not possible to compare data over uneven
time series of each patient using conventional statistical methods. We further normalized the data to
account for irregular sampling intervals. Univariate analyses were performed to identify features that
were associated with brain injury (Wilcoxon rank-sum test, p < 0.01). Five features were identified:
Base Excess Maximum, Glucose minimum, glucose median, pCO2 minimum, and pH minimum.
They were used as inputs to train a multivariate logistic regression predictor and the performance was
evaluated through using k-fold cross validation (5 subsample groups).
3. Results
3.1. Patients
The final model included 174 patients. Patient characteristics are in Tables 1 and 2. Fifty-one
percent had brain injury. Of the injured patients, fifty-eight percent had a predominantly ischemic
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injury and forty-two percent had a predominantly hemorrhagic injury. There were no statistically
significant differences between patients with and without brain injury with regards to ECMO indication,
ECMO type, or gender. Differences existed in the age groups as seen in Table 2.
Table 1. Demographic and clinical characteristics of patients included in the study.
Demographics of Patients in Database
Age Range 0–18 years




Weight (kg) Range 1.9–132
Median (IQR) 5.9 (14.2)
ECMO Type Venoarterial 106 (61%)
Venovenous 68 (39%)
ECMO Primary Indication Cardiac 49 (28%)
Non-cardiac 125 (72%)
ECMO Run Length (hours) Range 14–985
Median (IQR) 129 (165)
Injury Status Injury 89 (51%)
No injury 85 (49%)
Table 2. Characteristics of patients in the injury vs no injury groups.
Patient Characteristics
Neurological Injury No Neurological injury p
Primary ECMO indication (total n: 174)
Non-cardiac 64 61 0.85
Cardiac 25 24 0.50
Initial mode of ECMO (total n: 174)
Venoarterial 61 45 0.12
Venovenous 28 40 0.15
Gender (total n: 174)
Male 49 43 0.53
Female 40 42 0.83
Age (total n: 174)
Neonate (0–30 days) 38 32 0.47
Infant (1–12 months) 8 21 0.02 *
Child (1–12 years) 35 19 0.03 *
Adolescent (>12 years) 8 13 0.28
Survived to hospital discharge 76% 72% 0.74
* Statistically Significant at 95% Confidence Interval.
All neonates in this cohort were full-term. The median time from ICU admission to ECMO
cannulation was one day. All patients received a heparin bolus prior to the initiation of ECMO, and all
patients were managed with centrifugal pumps. Peripheral vessels were used for ECMO cannulation
in 125 patients, and central cannulation was used in 49 patients.
3.2. Injury Prediction Based on Neural Networks
The developed models included over 35,000 clinical hours on ECMO and 1.4 million data points
across 35 variables. Figure 3a shows the resulting confusion matrix. Radiographic brain injury was
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predicted with an Area Under the Curve (AUC) of 0.76. The model demonstrated 73% sensitivity for
predicting radiographic brain injuries in our cohort. The model’s specificity was 80%, indicating good
discrimination. The positive predictive value was 78% and the negative predictive value was 75%.
The model’s F1 score, a measure of precision and recall, was 0.76.
Feature masking was performed to help elucidate which factors played a greater role in the
model’s predictive ability. Physiological data had the highest impact on model accuracy. Other category
groups had little to no impact on the model, as shown in Figure 3d and Table A2. Detailed model
results are in the Appendix A, in Table A3 and Figure A2a–f.
Following this, the model was restricted to the first 48 or 120 h of data, including the pre-cannulation
period. The resulting models demonstrated poor accuracy based on AUC values; Figure A1 shows
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confusion matrix. (c) Matrix based on clinician suspicion for occurrence of injury. (d) Results of 
permutation feature importance, and relative importance for each variable group. 
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This study describes a novel approach to understand ECMO-related radiographic brain injury 
based on the comprehensive incorporation of ECMO-run clinical factors into a machine learning 
model. Despite incorporating a heterogeneous population with varying ECMO indications and 
clinical courses, the model displayed fair performance metrics as evidenced by an AUC of 0.76 and 
an F1 score of 0.76. The model had a positive predictive value (PPV) of 78%. Clinician judgment in 
patients suspected of injury had an overall accuracy of 54%, with a PPV of 57%. A traditional 
multivariate logistic regression model demonstrated a predictive accuracy of 61% and a PPV of 63%. 
Given the historically opaque cause of ECMO related neurologic injury, lessons learned from this 
work set the framework for prospective work with a larger more granular dataset. 
The use of feature masking allowed us to run the model repeatedly while systematically 
removing groups of variables [26,27]. The technique provided an indirect assessment of different 
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confusion matrix. (c) Matrix based on clinician suspicion for occurrence of injury. (d) Results of
permutation feature importance, and relative importance for each variable group.
3.3. Clinician Suspicion for Injury
Injury was suspected by the clinical team in 61 of the 174 patients (35%), all of whom underwent
intra-run head CTs. Of these patients, 35 (57%) demonstrated moderate to severe radiographic brain
injury. 26 demonstrated no significant injury. To encompass the progressive nature and possible
radiographic delay of brain i jury, a true negative was counted s a patie t who was scan ed intra-run
and was n t found to have an injury post-ru . Clinical suspicion of injury had a sensitivity of 39% and
specificity of 69%. The positive predictive value was 57% and the negative predictive value was 52%
(Figure 3c and Table A3).
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3.4. Injury Prediction Based on Conventional Methods
A total of 5 of the 35 variables within the first 48 h were associated with brain injury by univariate
analysis. The multivariate logistic regression conducted on these five features demonstrated an AUC
of 0.61, with a 62% sensitivity and 61% specificity (Figure 3b and Table A3).
4. Discussion
This study describes a novel approach to understand ECMO-related radiographic brain injury
based on the comprehensive incorporation of ECMO-run clinical factors into a machine learning
model. Despite incorporating a heterogeneous population with varying ECMO indications and clinical
courses, the model displayed fair performance metrics as evidenced by an AUC of 0.76 and an F1
score of 0.76. The model had a positive predictive value (PPV) of 78%. Clinician judgment in patients
suspected of injury had an overall accuracy of 54%, with a PPV of 57%. A traditional multivariate
logistic regression model demonstrated a predictive accuracy of 61% and a PPV of 63%. Given the
historically opaque cause of ECMO related neurologic injury, lessons learned from this work set the
framework for prospective work with a larger more granular dataset.
The use of feature masking allowed us to run the model repeatedly while systematically removing
groups of variables [26,27]. The technique provided an indirect assessment of different variables’
significance to the model. Hemodynamics, including perturbations in heart rates and blood pressures,
had the greatest association with the prediction of occurrence of injury. Markers of coagulation and
hemolysis, traditionally thought to significantly contribute to neurologic injury, had minimal impact
on the model’s accuracy—consistent with some recent reports in the literature [10]. Acid-base status,
vasoactive drug dosage, and ECMO machine settings had an insignificant effect on injury incidence.
While cause and effect are unknown, this analysis indicates attention to hemodynamic parameters may
be a fruitful direction for future research.
In contrast to the model’s 73% sensitivity and 80% specificity, clinician judgment had an overall
accuracy of 54% with sensitivity of 39% and specificity of 69%. The model had a positive predictive
value of 78%, opposed to a clinician PPV of 57%. Within this group, nearly half of the patients not
clinically suspected to have an injury ended up with radiographic evidence of injury following their
ECMO run. For an injury with grave consequences, missing a significant number of injuries until
imaging following ECMO delays the ability to mitigate the effects of an injury. This demonstrates the
need for better predictive modeling. The traditional multivariate logistic regression model was only
marginally better, with a predictive accuracy of 61%, 62% sensitivity and 61% specificity.
Previously published clinical applications for neural networks include predicting mortality in the
critical care setting [28,29], predicting the occurrence of severe sepsis [30,31], and identifying optimal
approaches to treat infection [32]. These studies demonstrate the applicability of neural networks to
questions in clinical medicine and utilized similar approaches to examine complex clinical relationships.
To our knowledge, there are no previously developed tools that analyze brain injury on ECMO.
There are other ECMO-related outcomes for which predictive tools have been designed.
An example is the P-PREP (Pediatric Pulmonary Rescue with ECMO Prediction) score. This score aimed
to predict mortality at the time of ECMO initiation for children with respiratory failure (AUC 0.66) [14].
Such tools, however, use logistic regression to identify variables that contribute to the outcome.
This approach presupposes a linear, non-complex relationship between input and outcome and thus
cause and effect [33]. A machine learning approach provides more comprehensive and inclusive insight
into these types of data.
Our institution adopted a unique practice of routine post-ECMO head imaging of non-cardiac
patients when clinically stable—regardless of overt neurologic indication. This allowed for the
identification of injuries that may have otherwise not been detected and may explain the higher
incidence of brain injury within our cohort. Furthermore, patients treated with ECMO for cardiac
indications were often not imaged if injury was not suspected. Limiting the analysis to the subset of
patients with imaging, and not the entire cohort of patients, allowed us to provide the model with
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a defined outcome. The exclusion of cardiac bypass patients helped avoid potential confounders or
brain injuries that may have been sustained prior to ECMO. Additionally, we excluded patients with
known brain injury or abnormal imaging pre-ECMO to limit further confounders. Overall, our patient
population is representative of pediatric ECMO-supported patients at large tertiary care centers.
Limitations
A neural network’s predictive ability is improved with larger datasets. For a pediatric ECMO
study, our dataset is large. In machine learning, 174 patients represent a small dataset, even if
compensated for by the number of data points available per patient. Our dataset is susceptible to
biases expected from a model trained and validated on patients from a single center, possibly affecting
the model’s external validity. A model analyzing a large, more homogenous population will have
better accuracy and external validity. We were also limited by utilizing only neuroimaging as our
outcome, which may not correlate as well with functional neurodevelopmental outcomes in some
patient groups. Our outcome of interest was radiographic neurologic injury, but by selecting only
patients with post ECMO imaging, we may have introduced a selection bias. Nevertheless, based on
other work in our institution, we do know that imaged and non-imaged patients are very similar from
a demographic and outcome characteristic standpoint.
The lack of portable CTs in our center may have resulted in missing some injured patients if death
occurred before decannulation, or if the patient was too unstable for transport. Excluding cardiac
bypass patients, although undertaken due to missing clinical information, adds additional selection
bias to this study. Any selection bias can result in erroneous conclusions including overestimated
positive predictive values.
The retrospective review of the medical record may not be an accurate representation of true
clinician suspicion, since some decisions may not be wholly captured in the record, and selection bias
may exist. Finally, despite the feature masking performed, the inherent nature of neural networks
prevents accurate interrogation of specific layers and weights generated by the model. This is especially
true as features were analyzed in groups, and there may be covariance between variables that may
over- or underestimate the contribution of any given feature group.
5. Conclusions
The etiology of brain injury on ECMO is complex and multifactorial. In this paper, we present a
neural network’s predictive ability to identify radiographic brain injury, compared to both traditional
statistical methods and clinical suspicion. We utilize feature masking to demonstrate that perturbations
in hemodynamic parameters had the highest impact on the ability of our model to predict radiographic
brain injury. Coagulation factors, which traditionally have been suspected to precipitate brain injury,
had limited effect. Future application of this prediction model using more granular data in real-time
will help improve our understanding of neurological injury on ECMO.
In a field that has been historically difficult to crack, these findings lay the foundation for further
areas of research directions. This work also illustrates the need for the development of a real-time
risk prediction model in order to advance the field towards the active optimization of treatments to
mitigate these risks.
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Appendix A
Table A1. Breakdown of which variables were included within each group.
Variable
Group Included Variables



























































pressure SpO2 Heart Rate Temp (
◦C)
* Glucose not included in this group for permutation feature importance.
Table A2. Magnitude of variable group importance to final model predictions following feature masking.




Markers of perfusion 0.52
Vasoactives 0.48
Physiological data 0.92
Table A3. Detailed statistical results of all assessed models in study.
Model Sensitivity Specificity PPV NPV +LR −LR AUC
Complete Model 73% 80% 78% 75% 3.65 0.38 0.76
Alternate assessments:
Clinician suspicion 39% 69% 57% 52% 1.29 0.87 0.54
Logistic Regression 62% 61% 63% 60% 1.59 0.62 0.61
Permutation feature importance and data-groups excluded:
Acid-base 55% 71% 66% 60% 1.87 0.64 0.62
Coagulation 73% 60% 66% 68% 1.83 0.45 0.67
Machine factors 82% 40% 59% 68% 1.37 0.45 0.61
Markers of
perfusion 64% 60% 63% 62% 1.60 0.60 0.62
Vasoactives 55% 70% 66% 60% 1.87 0.64 0.63
Physiological data 55% 51% 54% 52% 1.11 0.90 0.53
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Figure A1. (a) Demonstrates model’s confusion matrix when limited to only initial 48 h of data. (b) 





Figure A1. (a) Demonstrates model’s confusion t i li ited to only initial 48 h of dat .
(b) Demonstrates model’s confusion matrix when limited to only initial 120 h of data.




Figure A1. (a) Demonstrates model’s confusion matrix when limited to only initial 48 h of data. (b) 










Figure A2. (a) Demonstrates model’s confusion matrix when after removal of acid-base factors during 
feature masking. (b) Demonstrates model’s confusion matrix when after removal of coagulation 
factors during feature masking. (c) Demonstrates model’s confusion matrix when after removal of 
ECMO machine factors during feature masking. (d) Demonstrates model’s confusion matrix when 
after removal of markers of perfusion during feature masking. (e) Demonstrates model’s confusion 
matrix when after removal of vital signs during feature masking. (f) Demonstrates model’s confusion 
matrix when after removal of vasoactives during feature masking. 
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